Developing AIDS care in Zimbabwe: a case for residential community centres? NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Developing AIDS care in Zimbabwe: a case for residential community centres?

AIDS Care. 1995;7(5):663-73. Unique Identifier : AIDSLINE MED/96263772
Jackson H; Kerkhoven R; Southern Africa AIDS Information Dissemination Service, Harare,; Zimbabwe.

Abstract: New support services are needed as the AIDS epidemic escalates. Home care has been the cornerstone of new developments in Zimbabwe and the southern African region, essentially resource-strapped countries. However, while home care has many benefits, levels of coverage are often low and many patients at some phase of their disease need more than their home can provide, even with access to support services. Hospital admission is often not a viable option and the need may arise for some form of respite or hospice community centre to provide residential care. This option is debated and potential benefits and pitfalls are explored.
Keywords: Community Health Centers/*ORGANIZATION & ADMIN *Community Health Planning Consumer Participation Home Care Services/ORGANIZATION & ADMIN Hospice Care/ORGANIZATION & ADMIN Human *HIV Infections/NURSING Medical Assistance Residential Facilities/*ORGANIZATION & ADMIN Social Work Terminal Care/ORGANIZATION & ADMIN Zimbabwe JOURNAL ARTICLEKWDcommunityhealthcenters/KWDorganization&adminKWDcommunityhealthplanningconsumerparticipationhomecareservices/organization&adminhospicecare/organization&adminhumanKWDhivinfections/nursingmedicalassistanceresidentialfacilities/KWDorganization&adminsocialworkterminalcare/organization&adminzimbabwejournalarticle
961030
M96A1444

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .